DrugDashboards

Mycophenolate Mofetil

Mycophenolate Mofetil · MYCOPHENOLATE MOFETIL 500 mg/20mL · Injection, Powder, Lyophilized, For Solution · Intravenous · Mylan Institutional LLC

NDC 67457-0386-81 · 4 VIAL in 1 CARTON / 20 mL in 1 VIAL · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. A Class II recall hit this product in the past year (Mylan Pharmaceuticals Inc).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$0.3990per billing unit (10 MG)HCPCS J7519 · Jul 1, 2026
  • Part D plans paid (avg)$0.6454per dosage unitgross, before rebates — matched by drug name · 2024

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$290.00
Reported to Texas DSHS · 2026 annual filing · Mylan Institutional Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MG
$0.399
HCPCS J7519 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $122.43 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA203859
TE code
AP
Approval date
Mar 31, 2017
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · OngoingJul 2, 2026
    MYLAN PHARMACEUTICALS INC — Presence of precipitate

Manufacturers of Mycophenolate Mofetil (Injection, Powder, Lyophilized, For Solution)

LabelerStrengthFirst seenLast seen
Meitheal Pharmaceuticals Inc.MYCOPHENOLATE MOFETIL 500 mg/20mLJul 15, 2026Sep 3, 2026
Armas Pharmaceuticals IncMYCOPHENOLATE MOFETIL 500 mg/20mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCMYCOPHENOLATE MOFETIL 500 mg/20mLJul 15, 2026Sep 2, 2026
Onesource Specialty Pharma LimitedMYCOPHENOLATE MOFETIL 500 mg/20mLJul 15, 2026Sep 2, 2026
Par Health USA, LLCMYCOPHENOLATE MOFETIL 500 mg/20mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Mycophenolate Mofetil — NDC 67457-0386-81," retrieved September 3, 2026, https://drugdashboards.com/drug/67457038681.

Free to cite with attribution — see how the data is put together.